AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
{{expandStatus?'Exit ':''}}Advanced Search
Optical coherence tomography (OCT) has gained considerable attention in interventional cardiovascular medicine and is currently used in clinical settings to assess atherosclerotic lesions and to optimize stent placement. Artery imaging at the cellular level constitutes the first step towards cardiovascular molecular imaging, which represents a major advance in the development of personalized noninvasive therapies. In this work, we demonstrate that cardiovascular OCT can be used to detect individual cells suspended in biocompatible fluids. Importantly, the combination of this catheter-based clinical technique with gold nanoshells (GNSs) as intracellular contrast agents led to a substantial enhancement in the backscattered signal produced by individual cells. This cellular contrast enhancement was attributed to the large backscattering cross-section of GNSs at the OCT laser wavelength (1, 300 nm). A simple intensity analysis of OCT cross-sectional images of suspended cells makes it possible to identify the sub-population of living cells that successfully incorporated GNSs. The generalizability of this method was demonstrated using two different cell lines (HeLa and Jurkat cells). This work provides novel insights into cardiovascular molecular imaging using specifically modified GNSs.
Fercher, A. F.; Drexler, W.; Hitzenberger, C. K.; Lasser, T. Optical coherence tomography-principles and applications. Rep. Prog. Phys. 2003, 66, 239–303.
Alfonso, F.; Sandoval, J.; Cárdenas, A.; Medina, M.; Cuevas, C.; Gonzalo, N. Optical coherence tomography: From research to clinical application. Minerva Med. 2012, 103, 441–464.
Ashok, P. C.; Praveen, B. B.; Bellini, N.; Riches, A.; Dholakia, K.; Herrington, C. S. Multi-modal approach using Raman spectroscopy and optical coherence tomography for the discrimination of colonic adenocarcinoma from normal colon. Biomed. Opt. Express 2013, 4, 2179–2186.
Fujimoto, J. G. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat. Biotechnol. 2003, 21, 1361–1367.
Mattison, S. P.; Kim, W.; Park, J.; Applegate, B. E. Molecular imaging in optical coherence tomography. Curr. Mol. Imaging 2014, 3, 88–105.
Zysk, A. M.; Nguyen, F. T.; Oldenburg, A. L.; Marks, D. L.; Boppart, S. A. Optical coherence tomography: A review of clinical development from bench to bedside. J. Biomed. Opt. 2007, 12, 051403.
Bouma, B. E.; Yun, S. -H.; Vakoc, B. J.; Suter, M. J.; Tearney, G. J. Fourier-domain optical coherence tomography: Recent advances toward clinical utility. Curr. Opin. Biotechnol. 2009, 20, 111–118.
Alfonso, F.; Dutary, J.; Paulo, M.; Gonzalo, N.; Pérez- Vizcayno, M. J.; Jiménez-Quevedo, P.; Escaned, J.; Bañuelos, C.; Hernández, R.; Macaya, C. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Heart 2012, 98, 1213–1220.
Bezerra, H. G.; Costa, M. A.; Guagliumi, G.; Rollins, A. M.; Simon, D. I. Intracoronary optical coherence tomography: A comprehensive review: Clinical and research applications. JACC: Cardiovasc. Interv. 2009, 2, 1035–1046.
Prati, F.; Stazi, F.; Dutary, J.; La Manna, A.; Di Giorgio, A.; Pawlosky, T.; Gonzalo, N.; Di Salvo, M. E.; Imola, F.; Tamburino, C. et al. Detection of very early stent healing after primary angioplasty: An optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The detective study. Heart 2011, 97, 1841–1846.
Rivero, F.; Bastante, T.; Cuesta, J.; Benedicto, A.; Restrepo, J. A.; Alfonso, F. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: Optical coherence tomography insights. Can. J. Cardiol. 2015, 31, 255–259.
Douma, K.; Prinzen, L.; Slaaf, D. W.; Reutelingsperger, C. P. M.; Biessen, E. A. L.; Hackeng, T. M.; Post, M. J.; van Zandvoort, M. A. M. J. Nanoparticles for optical molecular imaging of atherosclerosis. Small 2009, 5, 544–557.
Chen, J. Y.; Saeki, F.; Wiley, B. J.; Cang, H.; Cobb, M. J.; Li, Z. -Y.; Au, L.; Zhang, H.; Kimmey, M. B.; Li, X. D. et al. Gold nanocages: Bioconjugation and their potential use as optical imaging contrast agents. Nano Lett. 2005, 5, 473–477.
Bibikova, O.; Popov, A.; Bykov, A.; Prilepskii, A.; Kinnunen, M.; Kordas, K.; Bogatyrev, V.; Khlebtsov, N.; Vainio, S.; Tuchin, V. Optical properties of plasmon-resonant bare and silica-coated nanostars used for cell imaging. J. Biomed. Opt. 2015, 20, 076017.
Skrabalak, S. E.; Chen, J.; Au, L.; Lu, X.; Li, X.; Xia, Y. Gold nanocages for biomedical applications. Adv. Mater. 2007, 19, 3177–3184.
Gobin, A. M.; Lee, M. H.; Halas, N. J.; James, W. D.; Drezek, R. A.; West, J. L. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett. 2007, 7, 1929–1934.
Hu, J.; Rivero, F.; Torres, R. A.; Ramírez, H. L.; Rodríguez, E. M.; Alfonso, F.; Solé, J. G.; Jaque, D. Dynamic single gold nanoparticle visualization by clinical intracoronary optical coherence tomography. J. Biophotonics 2017, 10, 674–682.
Skala, M. C.; Crow, M. J.; Wax, A.; Izatt, J. A. Photothermal optical coherence tomography of epidermal growth factor receptor in live cells using immunotargeted gold nanospheres. Nano Lett. 2008, 8, 3461–3467.
Loo, C.; Lowery, A.; Halas, N.; West, J.; Drezek, R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 2005, 5, 709–711.
De León, Y. P.; Pichardo-Molina, J. L.; Ochoa, N. A.; Luna-Moreno, D. Contrast enhancement of optical coherence tomography images using branched gold nanoparticles. J. Nanomater. 2012, 2012, 571015.
De La Zerda, A.; Prabhulkar, S.; Perez, V. L.; Ruggeri, M.; Paranjape, A. S.; Habte, F.; Gambhir, S. S.; Awdeh, R. M. Optical coherence contrast imaging using gold nanorods in living mice eyes. Clin. Exp. Ophthalmol. 2015, 43, 358–366.
Adler, D. C.; Huang, S. -W.; Huber, R.; Fujimoto, J. G. Photothermal detection of gold nanoparticles using phase- sensitive optical coherence tomography. Opt. Express 2008, 16, 4376–4393.
Fratoddi, I.; Venditti, I.; Cametti, C.; Russo, M. V. How toxic are gold nanoparticles? The state-of-the-art. Nano Res. 2015, 8, 1771–1799.
Masters, J. R. HeLa cells 50 years on: The good, the bad and the ugly. Nat. Rev. Cancer 2002, 2, 315–319.
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63.
Li, M.; Lohmüller, T.; Feldmann, J. Optical injection of gold nanoparticles into living cells. Nano Lett. 2015, 15, 770–775.
Cui, Y.; Wang, X. L.; Ren, W.; Liu, J.; Irudayaraj, J. Optical clearing delivers ultrasensitive hyperspectral dark-field imaging for single-cell evaluation. ACS Nano 2016, 10, 3132–3143.
Wax, A.; Sokolov, K. Molecular imaging and darkfield microspectroscopy of live cells using gold plasmonic nanoparticles. Laser Photonics Rev. 2009, 3, 146–158.
Qian, W.; Huang, X. H.; Kang, B.; El-Sayed, M. A. Dark-field light scattering imaging of living cancer cell component from birth through division using bioconjugated gold nanoprobes. J. Biomed. Opt. 2010, 15, 046025.
Jaque, D.; Maestro, L. M.; del Rosal, B.; Haro-Gonzalez, P.; Benayas, A.; Plaza, J. L.; Rodríguez, E. M.; Solé, J. G. Nanoparticles for photothermal therapies. Nanoscale 2014, 6, 9494–9530.
京公网安备11010802044758号